Douglas E. Feltner

Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Serotonin Transporter-Deficient Mic

Dietmar Bengel, Dennis L. Murphy, Anne M. Andrews et al. · Molecular Pharmacology · 1998 · 710 citations

Life Sciences, Neuroscience, Pharmacology +8

Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli.

Wayne A. Marasco, Sem H. Phan, Henry C. Krutzsch et al. · Journal of Biological Chemistry · 1984 · 526 citations · Full text

Life Sciences, Biochemistry, Microbiology +12

Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial

Richard S. Finkel, Claudia A. Chiriboga, Anne M. Connolly et al. · The Lancet Neurology · 2021 · 480 citations

Medicine, Genetics, Molecular Genetics +14

Vocal Acoustic Biomarkers of Depression Severity and Treatment Response

James C. Mundt, Adam P. Vogel, Douglas E. Feltner et al. · Biological Psychiatry · 2012 · 327 citations

Education, Psychiatry, Speech-language Pathology +14

Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled Trial

Atul C. Pande, Jerri G. Crockatt, Douglas E. Feltner et al. · American Journal of Psychiatry · 2003 · 317 citations

Medicine, Pharmacotherapy, Psychiatry +17